Viveve Medical Inc

Company Profile

Viveve Medical Inc had its IPO on 2001-01-02 under the ticker symbol VIVE.

The company operates in the Healthcare sector and Medical Devices industry. Viveve Medical Inc has a staff strength of 47 employees.

Stock update

Shares of Viveve Medical Inc opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a +50% increase from the previous day's closing price.

A total volume of 200 shares were traded at the close of the day’s session.

In the last one week, shares of Viveve Medical Inc have increased by +50%.

Viveve Medical Inc's Key Ratios

Viveve Medical Inc has a market cap of $34317, indicating a price to book ratio of 3.6229 and a price to sales ratio of 0.66.

In the last 12-months Viveve Medical Inc’s revenue was $6.83 million with a gross profit of $620000 and an EBITDA of $-20335000. The EBITDA ratio measures Viveve Medical Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Viveve Medical Inc’s operating margin was -309.73% while its return on assets stood at -62.13% with a return of equity of -210.99%.

In Q3, Viveve Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 4.2%.

Viveve Medical Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

-0.13

Its diluted EPS in the last 12-months stands at $-2.65 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -0.13. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Viveve Medical Inc’s profitability.

Viveve Medical Inc stock is trading at a EV to sales ratio of 0.6246 and a EV to EBITDA ratio of -0.2087. Its price to sales ratio in the trailing 12-months stood at 0.66.

Viveve Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$12.15 million

Total Liabilities

$10.84 million

Operating Cash Flow

$-193000.00

Capital Expenditure

$193000

Dividend Payout Ratio

0%

Viveve Medical Inc ended 2024 with $12.15 million in total assets and $0 in total liabilities. Its intangible assets were valued at $12.15 million while shareholder equity stood at $1.18 million.

Viveve Medical Inc ended 2024 with $0 in deferred long-term liabilities, $10.84 million in other current liabilities, 1000.00 in common stock, $-258514000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $5.91 million and cash and short-term investments were $5.91 million. The company’s total short-term debt was $5,881,000 while long-term debt stood at $0.

Viveve Medical Inc’s total current assets stands at $9.60 million while long-term investments were $0.00 and short-term investments were $0. Its net receivables were $860000.00 compared to accounts payable of $1.11 million and inventory worth $1.62 million.

In 2024, Viveve Medical Inc's operating cash flow was $-193000.00 while its capital expenditure stood at $193000.

Comparatively, Viveve Medical Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0

52-Week High

$1

52-Week Low

$0.001

Analyst Target Price

$3.1

Viveve Medical Inc stock is currently trading at $0 per share. It touched a 52-week high of $1 and a 52-week low of $1. Analysts tracking the stock have a 12-month average target price of $3.1.

Its 50-day moving average was $0 and 200-day moving average was $0.12 The short ratio stood at 4.15 indicating a short percent outstanding of 0%.

Around 0.1% of the company’s stock are held by insiders while 25.8% are held by institutions.